Susono, Japan

Kumi Hosoi


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kumi Hosoi: Innovator in Propanolamine Derivatives

Introduction

Kumi Hosoi is a notable inventor based in Susono, Japan. She has made significant contributions to the field of pharmaceuticals, particularly through her work on propanolamine derivatives. With a total of 2 patents, her innovations have the potential to impact various medical treatments.

Latest Patents

One of Kumi Hosoi's latest patents involves new propanolamine derivatives or salts thereof. These compounds are represented by a specific formula and are designed to exhibit gut-selective sympathomimetic, anti-ulcerous, anti-pancreatitis, lipolytic, anti-urinary incontinence, and anti-pollakiuria activities. The patent also details processes for the preparation of these derivatives, a pharmaceutical composition comprising them, and methods for preventing and/or treating diseases as indicated in the specification for both humans and animals.

Career Highlights

Throughout her career, Kumi Hosoi has worked with prominent companies in the pharmaceutical industry. Notably, she has been associated with Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. Her work in these organizations has allowed her to develop her expertise and contribute to significant advancements in pharmaceutical science.

Collaborations

Kumi has collaborated with esteemed colleagues such as Kiyoshi Taniguchi and Minoru Sakurai. These partnerships have fostered an environment of innovation and have led to the successful development of her patented technologies.

Conclusion

Kumi Hosoi's contributions to the field of pharmaceuticals, particularly through her work on propanolamine derivatives, highlight her role as an influential inventor. Her patents and collaborations reflect her commitment to advancing medical science and improving treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…